CD4+CD25+ regulatory T cells inhibit the maturation but not the initiation of an autoantibody response

被引:64
作者
Fields, ML [1 ]
Hondowicz, BD [1 ]
Metzgar, MH [1 ]
Nish, SA [1 ]
Wharton, GN [1 ]
Picca, CC [1 ]
Caton, AJ [1 ]
Erikson, J [1 ]
机构
[1] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA
关键词
D O I
10.4049/jimmunol.175.7.4255
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To investigate the mechanism by which T regulatory (Treg) cells may control the early onset of autoimmunity, we have used an adoptive transfer model to track Treg, Th, and anti-chromatin B cell interactions in vivo. We show that anti-chromatin B cells secrete Abs by day 8 in vivo upon provision of undeviated, Th1- or Th2-type CD4(+) T cell help, but this secretion is blocked by the coinjection of CD4(+)CD25(+) Treg cells. Although Treg cells do not interfere with the initial follicular entry or activation of Th or B cells at day 3, ICOS levels on Th cells are decreased. Furthermore, Treg cells must be administered during the initial phases of the Ab response to exert full suppression of autoantibody production. These studies indicate that CD25(+) Treg cells act to inhibit the maturation, rather than the initiation, of autoantibody responses.
引用
收藏
页码:4255 / 4264
页数:10
相关论文
共 57 条
[1]   Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation [J].
Asano, M ;
Toda, M ;
Sakaguchi, N ;
Sakaguchi, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :387-396
[2]   An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation [J].
Asseman, C ;
Mauze, S ;
Leach, MW ;
Coffman, RL ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :995-1003
[3]   Differential effect of neonatal thymectomy on systemic and organ-specific autoimmune disease [J].
Bagavant, H ;
Thompson, C ;
Ohno, K ;
Setiady, Y ;
Tung, KSK .
INTERNATIONAL IMMUNOLOGY, 2002, 14 (12) :1397-1406
[4]   In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines [J].
Barrat, FJ ;
Cua, DJ ;
Boonstra, A ;
Richards, DF ;
Crain, C ;
Savelkoul, HF ;
de Waal-Malefyt, R ;
Coffman, RL ;
Hawrylowicz, CM ;
O'Garra, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) :603-616
[5]   CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity [J].
Belkaid, Y ;
Piccirillo, CA ;
Mendez, S ;
Shevach, EM ;
Sacks, DL .
NATURE, 2002, 420 (6915) :502-507
[6]   B cells and professional APCs recruit regulatory T cells via CCL4 [J].
Bystry, RS ;
Aluvihare, V ;
Welch, KA ;
Kallikourdis, M ;
Betz, AG .
NATURE IMMUNOLOGY, 2001, 2 (12) :1126-1132
[7]   Chemokines in the systemic organization of immunity [J].
Campbell, DJ ;
Kim, CH ;
Butcher, EC .
IMMUNOLOGICAL REVIEWS, 2003, 195 :58-71
[8]   The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses [J].
Carreno, BM ;
Collins, M .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :29-53
[9]   LOW AVIDITY RECOGNITION OF A CLASS II-RESTRICTED NEO-SELF PEPTIDE BY VIRUS-SPECIFIC T-CELLS [J].
CERASOLI, DM ;
MCGRATH, J ;
CARDING, SR ;
SHIH, FF ;
KNOWLES, BB ;
CATON, AJ .
INTERNATIONAL IMMUNOLOGY, 1995, 7 (06) :935-945
[10]  
Cyster JG, 2000, IMMUNOL REV, V176, P181